79 related articles for article (PubMed ID: 10481525)
1. [The use of monoclonal antibodies in the detection of small cell lung cancer metastases in bone marrow].
Obłakowski P; Pacuszka T; Rogińska E; Remiszewski P; Załeska J; Zych J; Roszkowski K; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 1999; 67(1-2):53-9. PubMed ID: 10481525
[TBL] [Abstract][Full Text] [Related]
2. [Detection of small cell lung cancer metastases in the bone marrow in vitro using monoclonal antibodies].
Goncharskaia MA; Orel NF; Perevodchikova NI; Solov'eva EA
Biull Eksp Biol Med; 1996 Apr; 121(4):456-8. PubMed ID: 8829467
[No Abstract] [Full Text] [Related]
3. New serum markers for small-cell lung cancer. I. The ganglioside fucosyl-GM1.
Vangsted A; Drivsholm L; Andersen E; Pallesen T; Zeuthen J; Wallin H
Cancer Detect Prev; 1994; 18(3):221-9. PubMed ID: 8076384
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma.
Layer G; Steudel A; Schüller H; van Kaick G; Grünwald F; Reiser M; Schild HH
Cancer; 1999 Feb; 85(4):1004-9. PubMed ID: 10091781
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric detection of small cell lung cancer cells with aberrant CD45 expression in micrometastatic bone marrow.
Danbara M; Yoshida M; Kanoh Y; Jiang SX; Masuda N; Akahoshi T; Higashihara M
Jpn J Clin Oncol; 2009 Nov; 39(11):771-5. PubMed ID: 19674995
[TBL] [Abstract][Full Text] [Related]
6. Detection of small cell lung cancer bone marrow metastases by immunofluorescence.
Humblet Y; Canon JL; Sekhavat M; Feyens AM; Manouvriez P; Lebacq-Verheyden AM; Bazin H; Prignot J; Symann M
Pathol Biol (Paris); 1988 Jan; 36(1):25-8. PubMed ID: 2834687
[TBL] [Abstract][Full Text] [Related]
7. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
Bonner JA; Sloan JA; Rowland KM; Klee GG; Kugler JW; Mailliard JA; Wiesenfeld M; Krook JE; Maksymiuk AW; Shaw EG; Marks RS; Perez EA
Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
Hsu CP; Shen GH; Ko JL
Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461
[TBL] [Abstract][Full Text] [Related]
9. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
[TBL] [Abstract][Full Text] [Related]
10. Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer.
Chen LC; Brown AB; Cheung IY; Cheung NK; Kris MG; Krug LM
Lung Cancer; 2010 Feb; 67(2):216-20. PubMed ID: 19457569
[TBL] [Abstract][Full Text] [Related]
11. Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer.
Leonard RC; Duncan LW; Hay FG
Cancer Res; 1990 Oct; 50(20):6545-8. PubMed ID: 2170006
[TBL] [Abstract][Full Text] [Related]
12. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
[TBL] [Abstract][Full Text] [Related]
13. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal antibodies to human small-cell lung cancer].
Goncharskaia MA; Rutkevich IM; Tonevitskiĭ AG; Orel NF; Vasil'ev AV; Perevodchikova NI; Mechetner EB
Biull Eksp Biol Med; 1991 Sep; 112(9):282-5. PubMed ID: 1660741
[TBL] [Abstract][Full Text] [Related]
15. New serum markers for small-cell lung cancer. II. The neural cell adhesion molecule, NCAM.
Vangsted A; Drivsholm L; Andersen E; Bock E
Cancer Detect Prev; 1994; 18(4):291-8. PubMed ID: 7982239
[TBL] [Abstract][Full Text] [Related]
16. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
Schneider J; Philipp M; Salewski L; Velcovsky HG
Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival.
Kasimir-Bauer S; Schleucher N; Weber R; Neumann R; Seeber S
Oncol Rep; 2003; 10(2):475-82. PubMed ID: 12579292
[TBL] [Abstract][Full Text] [Related]
18. Effects of different immunolabeling techniques on the detection of small-cell lung cancer cells in bone marrow.
Pelosi G; Pasini F; Pavanel F; Bresaola E; Schiavon I; Iannucci A
J Histochem Cytochem; 1999 Aug; 47(8):1075-88. PubMed ID: 10424892
[TBL] [Abstract][Full Text] [Related]
19. Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Philipp M; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Clin Exp Med; 2003 Feb; 2(4):185-91. PubMed ID: 12624710
[TBL] [Abstract][Full Text] [Related]
20. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer.
Ohgami A; Mitsudomi T; Sugio K; Tsuda T; Oyama T; Nishida K; Osaki T; Yasumoto K
Ann Thorac Surg; 1997 Aug; 64(2):363-7. PubMed ID: 9262576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]